Phosphatidylserine-mediated phagocytosis of anticancer drug-treated cells by macrophages

Area of Science:

• Immunology
• Cell Biology
• Oncology

Background:

• Apoptotic cells are typically cleared rapidly by phagocytes.
• The mechanisms by which phagocytic cells recognize and engulf cancer cells undergoing drug-induced apoptosis are not fully understood.

Purpose of the Study:

• To investigate the recognition and phagocytosis of cancer cells undergoing apoptosis induced by anticancer drugs.
• To elucidate the role of phosphatidylserine externalization in this process.

Main Methods:

• Human leukemia (Jurkat) cells were treated with doxorubicin or bufalin to induce apoptosis.
• Apoptotic Jurkat cells were co-cultured with mouse peritoneal macrophages.
• The effects of Z-VAD-FMK (a caspase inhibitor) and phosphatidylserine-containing liposomes on phagocytosis were assessed.

Main Results:

• Anticancer drug treatment induced apoptosis and phosphatidylserine externalization in Jurkat cells.
• Efficient phagocytosis of apoptotic Jurkat cells by macrophages was observed.
• Both apoptosis and phagocytosis were inhibited by Z-VAD-FMK.
• Phagocytosis was significantly reduced when phosphatidylserine-containing liposomes were present.

Conclusions:

• Anticancer drugs induce apoptosis in cancer cells.
• This apoptosis involves externalization of phosphatidylserine.
• Phosphatidylserine serves as a signal for phagocytosis of these cancer cells by macrophages.
• The findings suggest a mechanism for the clearance of drug-treated cancer cells.